Alteration of SMRT Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas
Authors:
- 1 June 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (11) , 4554-4561
Abstract
Indolent non-Hodgkin lymphomas are characterized by a prolonged phase that is typically followed by a clinical progression associated with an accelerated clinical course and short survival time. Previous studies have not identified a consistent cytogenetic or molecular abnormality associated with transformation. The development of a transformed phenotype, evolving from the original low-grade component, most likely depends on multiple genetic events, including the activation of synergistic dominant oncogenes and a loss of tumor suppressor gene functions. Complex karyotypes and relatively bad chromosome morphology are typical of transformed non-Hodgkin lymphomas, rendering complete cytogenetic analysis difficult. Here, we report the use of transformed non-Hodgkin lymphoma cell lines and primary samples to identify the involvement of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene that maps at chromosome 12q24 in transformed non-Hodgkin lymphomas. We also show that down-regulation of SMRT in the immortalized “Weinberg's model” cell lines induces transformation of the cells. Assessment of cDNA array profiles should further help us to design a working model for SMRT involvement in non-Hodgkin lymphoma transformation as a novel, nonclassical tumor suppressor.Keywords
This publication has 50 references indexed in Scilit:
- A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activationBlood, 2004
- Silencing Mediator of Retinoid and Thyroid Hormone Receptors and Activating Signal Cointegrator-2 as Transcriptional Coregulators of the Orphan Nuclear Receptor Nur77Journal of Biological Chemistry, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Production and Effects of Interleukin-6 and Other Cytokines in Patients with Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1998
- Sinful repressionNature, 1997
- A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repressionNature, 1997
- CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.Journal of Experimental Medicine, 1996
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Recurrent mutation of immunoglobulin and c‐myc genes and differential expression of cell surface antigens occur in variant cell lines derived from a burkitt lymphomaInternational Journal of Cancer, 1990